Key points are not available for this paper at this time.
A fluorometric/colorimetric dual-channel chemosensor based on a hydrazine-substituted BODIPY probe has been successfully fabricated for the detection of RDX and PA. The chemosensor displays turn-on fluorescence behavior upon RDX with a detection limit of 85.8 nM, while showing a turn-off response to PA with a detection limit of 0.44 μM. Meanwhile, an obvious color difference is observed by the naked-eye after the reaction for RDX. Thus, in application, a two-to-two logic gate is constructed for potential application in explosives detection. Additionally, portable equipment is also developed for in situ determination of RDX.
Gao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: